Since inhibition of EGFR and HER-2 has been shown to reduce angiogenesis through an indirect effect on VEGF production [11,12], we evaluated whether lapatinib interferes with tumor angiogenesis in the A549 model in vivo. This evidence concerns the gene ERBB2 and neoplasm.